Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NSD2 | O96028 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | HTR6 | P50406 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | TERT | O14746 | 1/20 | 0.34 |
| ▸ | APP | P05067 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30879534 | 1.00 | NSD2 (0.40) | NSD2KDM4EHTR6L3MBTL1CA2 | |
| SCHEMBL23630294 | 0.85 | NSD2 (0.51) | NSD2KDM4EHTR6L3MBTL1CA2 | |
| SCHEMBL29948294 | 0.85 | NSD2 (0.51) | NSD2KDM4EHTR6L3MBTL1CA2 | |
| SCHEMBL10408524 | 0.77 | CA1 (0.42) | KDM4EHTR6CA2CA1CA9 | |
| SCHEMBL4463997 | 0.76 | TRPV4 (0.43) | L3MBTL1CA2CA1CA9MAPT | |
| SCHEMBL9418644 | 0.76 | HTR6 (0.41) | HTR6CA2CA1CA9LMNA | |
| SCHEMBL30727424 | 0.76 | TRPV4 (0.43) | L3MBTL1CA2CA1CA9MAPT | |
| SCHEMBL10408514 | 0.75 | CA1 (0.41) | KDM4EHTR6L3MBTL1CA2CA1 | |
| SCHEMBL8494394 | 0.75 | PLAU (0.50) | NSD2HTR6CA2CA1CA9 | |
| SCHEMBL5633017 | 0.75 | CYP2A6 (0.41) | HTR6CA2CA1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025129193-A1 | GLYCOSYLTRANSFERASES AND RELATED METHODS | NEW ENGLAND BIOLABS, INC. (US) | 2025-06-19 | — | — | WO | disclosed |
| EP-3469401-B1 | IMAGING TECHNOLOGIES | UNIV REGENSBURG (DE) | 2024-05-01 | — | — | EP | disclosed |
| EP-4360661-A1 | NANOPARTICLES FOR MEDICAL IMAGING AND TREATMENT | Universität Regensburg (DE) | 2024-05-01 | — | — | EP | disclosed |
| US-20230022745-A1 | Methods for Labeling a Population of RNA Molecules | NEW ENGLAND BIOLABS, INC. (US) | 2023-01-26 | — | — | US | disclosed |
| US-11479766-B2 | Methods for labeling a population of RNA molecules | NEW ENGLAND BIOLABS, INC. (US) | 2022-10-25 | — | — | US | disclosed |
| EP-3469401-A1 | IMAGING TECHNOLOGIES | Universitätsklinikum Regensburg (DE) | 2019-04-17 | — | — | EP | disclosed |
| US-20180195061-A1 | Methods for Labeling a Population of RNA Molecules | NEW ENGLAND BIOLABS, INC. (US) | 2018-07-12 | — | — | US | disclosed |
| EP-3279699-A1 | IMAGING TECHNOLOGIES | Universitätsklinikum Regensburg (DE) | 2018-02-07 | — | — | EP | disclosed |
| US-20160046981-A1 | Compositions and Methods for the Transfer of a Hexosamine to a Modified Nucleotide in a Nucleic Acid | NEW ENGLAND BIOLABS, INC. (US) | 2016-02-18 | — | — | US | disclosed |
| US-9200260-B2 | Compositions and methods for the transfer of a hexosamine to a modified nucleotide in a nucleic acid | NEW ENGLAND BIOLABS, INC. (US) | 2015-12-01 | — | — | US | disclosed |
| EP-0521985-B1 | CHIMERIC ANTIBODIES WITH RECEPTOR BINDING LIGANDS IN PLACE OF THEIR CONSTANT REGION | UNIV COLUMBIA (US) | 1997-09-24 | — | — | EP | disclosed |
| WO-1997030089-A1 | NOVEL ANTIBODY-CYTOKINE FUSION PROTEIN, AND METHODS OF MAKING AND USING THE SAME | REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1997-08-21 | — | — | WO | disclosed |
| US-5512667-A | Trifunctional intermediates for preparing 3'-tailed oligonucleotides | DRUG ROYALTY LP1 (CA) | 1996-04-30 | — | — | US | disclosed |
| US-5419966-A | Solid support for synthesis of 3'-tailed oligonucleotides | MICROPROBE CORPORATION (US) | 1995-05-30 | — | — | US | disclosed |
| EP-0547142-A4 | — | MICROPROBE CORP (US) | 1995-01-18 | — | — | EP | disclosed |
| EP-0547142-A1 | SOLID SUPPORT SYNTHESIS OF 3'-TAILED OLIGONUCLEOTIDES VIA A LINKING MOLECULE | EPOCH PHARMACEUTICALS, INC. (US) | 1993-06-23 | — | — | EP | disclosed |
| EP-0521985-A4 | CHIMERIC ANTIBODIES WITH RECEPTOR BINDING LIGANDS IN PLACE OF THEIR CONSTANT REGION | — | 1993-03-24 | — | — | EP | disclosed |
| EP-0521985-A1 | CHIMERIC ANTIBODIES WITH RECEPTOR BINDING LIGANDS IN PLACE OF THEIR CONSTANT REGION. | UNIV COLUMBIA (US) | 1993-01-13 | — | — | EP | disclosed |
| WO-1992003464-A1 | SOLID SUPPORT SYNTHESIS OF 3'-TAILED OLIGONUCLEOTIDES VIA A LINKING MOLECULE | MICROPROBE CORPORATION (US) | 1992-03-05 | — | — | WO | disclosed |
| WO-1991014438-A1 | CHIMERIC ANTIBODIES WITH RECEPTOR BINDING LIGANDS IN PLACE OF THEIR CONSTANT REGION | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 1991-10-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180195061-A1 | Methods for Labeling a Population of RNA Molecules | RNGTT, RNMT, MTAP | NSD2 2681/4885KDM4E 1517/4885HTR6 3708/4885 |
| US-11479766-B2 | Methods for labeling a population of RNA molecules | RNGTT, RNMT, MTAP | NSD2 2681/4885KDM4E 1517/4885HTR6 3708/4885 |
| US-20230022745-A1 | Methods for Labeling a Population of RNA Molecules | RNGTT, RNMT, MTAP | NSD2 2681/4885KDM4E 1517/4885HTR6 3708/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.